Jump to main content
Jump to site search

Issue 60, 2015
Previous Article Next Article

Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

Author affiliations

Abstract

The crystalline–amorphous parylene C structure was fabricated by Chemical Vapour Deposited (CVD) and functionalised in the micro- and nano-range with the oxygen plasma treatment. The evolution of thermal stability, structure and surface biocompatibility of parylene C films as an effect of oxygen plasma treatment time were evaluated by means of thermogravimetric/differential thermal analysis (TG/DTA), X-Ray Diffraction (XRD) and cells adhesion tests (crystal violet assay, fluorescence microscopy). The results are epitomized by a crystalline–amorphous parylene C structural model. It was found that the time of oxygen plasma treatment is critical for adhesion of osteoblast cells with the optimum of 5–8 minutes.

Graphical abstract: Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

Back to tab navigation

Publication details

The article was received on 09 Apr 2015, accepted on 22 May 2015 and first published on 27 May 2015


Article type: Paper
DOI: 10.1039/C5RA06366C
Author version
available:
Download author version (PDF)
Citation: RSC Adv., 2015,5, 48816-48821

  •   Request permissions

    Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

    M. Golda-Cepa, K. Engvall and A. Kotarba, RSC Adv., 2015, 5, 48816
    DOI: 10.1039/C5RA06366C

Search articles by author

Spotlight

Advertisements